Accreditation Information

Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activityfor a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

1. Discuss treatment options for cases presented.
2. Discuss management of complex cutaneous oncology cases.
3. Identify resources available to aid in making management decisions.

Target Audience

Dermatologists, dermatopathologists, dermatology residents, international graduate trainees.

Faculty Disclosure

Faculty, Planning Committe and CME Administrator disclosure:

Debjani Sahni, Speaker and Course Director, has no relevant financial relationships to disclose.

Ali Al-Haseni, Speaker and Planning Committee, has no relevant financial relationships to disclose.

Sakina Flint, RSS Coordinator, has no relevant financial relationships to disclose.

Faculty disclosure of off-label use:

Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Faculty disclosure policy:

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.